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Abstract
Aim This manuscript forms the final of seven that address
the surgical management of chronic constipation (CC) in
adults. The content coalesces results from the five system-
atic reviews that precede it and of the European Consensus
process to derive graded practice recommendations (GPR).
Methods Summary of review data, development of
GPR and future research recommendations as outlined
in detail in the ‘introduction and methods’ paper.
Results The overall quality of data in the five reviews was
poor with 113/156(72.4%) of included studies providing
only level IV evidence and only four included level I
RCTs. Coalescence of data from the five procedural
classes revealed that few firm conclusions could be drawn
regarding procedural choice or patient selection: no sin-
gle procedure dominated in addressing dynamic struc-
tural abnormalities of the anorectum and pelvic floor
with each having similar overall efficacy. Of one hundred
‘prototype’ GPRs developed by the clinical guideline
group, 85/100 were deemed ‘appropriate’ based on the
independent scoring of a panel of 18 European experts
and use of RAND-UCLA consensus methodology. The
remaining 15 were all deemed uncertain. Future research
recommendations included some potential RCTs but also
a strong emphasis on delivery of large multinational high-
quality prospective cohort studies.
Conclusion While the evidence base for surgery in CC
is poor, the widespread European consensus for GPRs
is encouraging. Professional bodies have the opportu-
nity to build on this work by supporting the efforts of
their membership to help convert the documented rec-
ommendations into clinical guidelines.
Keywords Constipation, surgery, obstructed defaecation
Introduction
This manuscript forms the final of seven that address
the surgical management of chronic constipation in
adults. The content coalesces results from the five sys-
tematic reviews that precede it and of the European
Consensus process to derive graded practice recommen-
dations.
Methods
These have been fully explained in the ‘Introduction
and Methods’ paper. Procedures have been grouped
as:
1 Colonic resection, including total colectomy, sub-
total and segmental colectomy (with some anasto-
motic variations for subtotal colectomy) by open and
laparoscopic approaches;
2 Rectal suspension procedures, including forms of
open and laparoscopic rectopexy;
3 Rectal excisional procedures, including stapled trans-
anal rectal resection (STARR) and intra-anal Delorme’s;
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4 Rectovaginal reinforcement procedures, including
trans-vaginal and trans-anal approaches with or with-
out mesh;
5 Sacral nerve stimulation.
Results have been presented as follows:
1 Summary tables of results where these could be com-
pared between classes of procedure based on homo-
geneous outcomes;
2 Graded practice recommendations. All prototype
GPRs have been documented with consensus statis-
tics and thence a clear indication of those that were
upheld (found to be appropriate) by consensus.
A final section addresses implications for future
research. Note: consideration was given to summarizing
all summary evidence statements in this manuscript
however these are covered in each individual review and
were omitted here for brevity.
Results
Study characteristics
Table 1 repeats the information provided in the ‘intro-
duction and methods’ paper on overall study character-
istics by procedure. As previously noted, the overall
quality of evidence was poor with 113/156 (72.4%)
providing only level IV evidence. The best evidence was
extracted for rectal excisional procedures where the
majority of studies were level I or II.
Summary of systematic review data
In each of the five reviews, results were presented for
perioperative variables, harms (post-operative complica-
tions and long-term adverse events), efficacy and prog-
nostic factors. These data have been presented together
below.
Perioperative variables
Data were available for nearly all procedure classes (except
SNS) on operation duration and length of stay (Table 2,
Figure 1). Not unsurprisingly, colectomy had the longest
operative duration and length of stay. For the three classes
of rectal procedure lengths of stay were similar, however
duration of surgery was clearly longer for rectal suspension
(rectopexy) and shortest for rectal excision - in effect for
forms of stapled trans-anal resection (STARR).
Harms
There were large discrepancies in harm recording with
selected outcomes being based on a priori knowledge of
recognized harms for each class of procedure. Given con-
siderable heterogeneity in reporting (covered in the indi-
vidual reviews), it was only possible to summarize main
harms semi-quantitatively (Table 3). A mortality rate of
approximately 1/200 occurred after colectomy. Other pro-
cedures had no recorded mortality or a very low rate (rec-
tovaginal reinforcement procedures: 1/1600). Colectomy
was associated with substantial risks in the short and long-
term, particularly in relation to small bowel obstruction
and poor functional outcomes. Other procedures had gen-
erally fewer complications, including some where review
data reflected concerns expressed widely in the interna-
tional surgical community, notably mesh complications
after rectopexy and chronic pain  urgency after STARR.
Efficacy
Few variables could be analysed across procedure classes on
the basis that, like harms, outcomes chosen tended to be
bespoke to each procedure class. It was however possible to
summarise global satisfaction ratings, i.e. the proportion of
patients self-reporting a good or excellent outcome.
Accepting the considerable limitations of such outcomes,
data in Table 4 show that all procedures are almost equally-
well received by patients with rates around 70–85% for all.
Table 1 Reviewed studies by main procedure type and evi-
dence level.
Procedure
Number of reviewed studies
by evidence level
1b 2b 3b 4 Total
Colonic resection 0 1 0 39 40
Rectal suspension procedures 0 2 0 16 18
Rectal excisional procedures 3 26 0 18 47
RV reinforcement procedures 1 10 0 33 44
Sacral nerve stimulation 0 0 0 7 7
ALL 4 39 0 113 156
RV, recto-vaginal.
Table 2 Summary of perioperative data for main classes of
procedure.
Procedure
Operation
Duration, mins
Length of Stay
(LOS), days
Mean
Range of
study means Mean
Range of
study means
Colonic resection 167 120–248 10.4 7.0–15.5
Rectal suspension 159 75–198 4.6 1.0–7.1
Rectal excision 44 23–95 3.0 1.0–8.0
RV reinforcement 67 20–169 3.9 1.0–9.0
SNS NK NK NK NK
RV, recto-vaginal; NK, not known.
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Patient selection
For most classes of procedure, some information could
be obtained about prognostic baseline characteristics
that might guide patient selection. In all instances, the
level of evidence was poor with no formal stratified
medicine studies and very few (if any) adequately pow-
ered post-hoc analyses of good quality cohort studies.
Table 5 summarizes the broad phenotypes of patients
that may most benefit from each procedure and some
negative prognostic features.
Graded practice recommendations
A series of tables (Table 6 a-e) show all GPRs proposed by
the clinical guideline group by main procedure class. The
outcomes of the consensus process have been presented as
median score (1–9) and by classification based on RAND-
UCLA methodology: appropriate; uncertain and inappro-
priate. The reader is reminded that appropriateness is not
directly extrapolated from the median score but rather the
overall data distribution (see introduction andmethods).
Discussion
This manuscript summarises the body of data from five
systematic reviews and presents new graded practice
recommendations.
Figure 1 Summary of perioperative data for main classes of
procedure, showing range of study means.
Table 3 Summary of perioperative complications and long-term adverse events
Procedure
Total perioperative
complications* Mortality† Specific adverse events*
Colonic resection 24.4% (17.8–31.7%) 6/1568 (0.4%) Small bowel obstruction: 15.2%, (RE: 10.2% to 20.9%)
Re-op: 13.3%, (RE: 8.6% to 18.7%)
Poor function: abdominal pain, bloating (20–50%),
rec. constipation (10–30%), diarrhea & incontinence (5–15%)
Rectal suspension 9.5% (6.1–13.1%) 0/1044 Minor complications predominate e.g. UTI
Some major poorly documented e.g. SBO
Mesh complications 0.5% (range 0–3.9%)
Rectal excision 16.9% (12.7–21.5%) 0/5896 PO bleeding: 1.6% (0.9% to 2.5%)
Sepsis: 0.2% (0.0% to 0.7%)
Anastomotic dehiscence: 0.3% (0.0% to 0.8%)
Rectal stenosis: 0.2% (0.0% to 0.6%)
Chronic anorectal pain: 0.7% (0.1% to 1.6%)
Chronic urgency: 5.2% (2.7% to 8.2%)
RV reinforcement 11.5% (7.2–16.6%) 2/3209(0.06%) Post-op. bleeding: 2.0% (0.7% to 3.6%)
Haematoma or sepsis: 0.9% (0.2% to 2.0%)
Dyspareunia: inadequately reported to analyse
SNS 22.7% (12.9–34.1%) 0/375 At least one reportable event: 58%
Infection: 0–7%
Device removal: 14.4% (7.8% to 22.5%)
*Pooled estimates based on random effects (RE) models with (95% CI); RV: recto-vaginal.
†denominator represents only those studies where mortality was recorded and documented.
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Summary of systematic review data
The overall quality of data was poor with 113/156
(72.4%) of included studies providing only level IV evi-
dence, thus greatly limiting the number and grade of
summary evidence statements. This was a particular prob-
lem for colonic resection, rectal suspension procedures
and sacral nerve stimulation, where nearly all data were
derived from level IV studies. The limitations of such
observational data are well acknowledged and are a
source of concern when used as a basis for promoting
procedures. For instance, colectomy for slow-transit con-
stipation would, based on systematic review of 40 obser-
vational studies, appear to be an attractive prospect with
86% global satisfaction rate (the highest of any of the
studied classes of procedure). However, recently pub-
lished US retrospective cohort data on over 2000
patients [1] paint a very different picture of high compli-
cation rates and greater long-term post-procedural health
utilization (ambulatory care, hospital admissions, radiol-
ogy etc.) than before surgery. It is difficult to reconcile
such disparity [2], and the increasing rates of colectomy
for constipation in the US [1] also seem at odds with
international opinion (that promotes extreme caution).
Sacral nerve stimulation also had generally supportive
observational evidence based on seven included studies.
However, subsequent randomised studies [3,4] directly
contradict these data and most centres no longer offer
SNS for the constipation indication.
Perhaps the greatest area of academic contention in
the pelvic floor community concerns the choice of pro-
cedure to address dynamic structural abnormalities of
the pelvic floor that lead to prolapse and obstructed
defaecation symptoms. The results presented here do
little to help resolve this issue and certainly cannot help
underpin a much needed treatment algorithm for such
patients. In effect, all have similar global satisfaction rat-
ings, similar lengths of stay and complication profiles
that are to some extent procedure-specific. Based on
reviewed indications, rectal suspension and excision pro-
cedures can be applied to patients with rectal intussus-
ception and/or rectocoele and rectovaginal
reinforcement procedures to rectocoele only. Aside
from a generally longer operating time for rectopexy
(and shorter for STARR), decision making for a patient
with one or both of these abnormalities currently rests
with personal views about the acceptability of certain
complications and (possibly) surgeon enthusiasm for
Table 4 Summary of efficacy data based on global satisfaction ratings.
Procedure No studies Total No patients Follow up (mean and range of means, months) Global satisfaction*
Colonic resection 40 2045 47 (12–132) 86 (81–89)%
Rectal suspension 18 1238 25 (12–72) 83 (74–91)%
RV reinforcement 44 3499 25 (12–74) 72 (67–77)%
Rectal wall excision 47 8340 23 (12–66) 76 (73–80)%
SNS 7 375 27 (20–51) 73 (57–87)%
*Pooled estimates based on random effects models with (95% CI).
Table 5 Patient characteristics influencing selection for each class of procedure
Procedure Main positive characteristic Secondary positive characteristics Negative characteristics
Colonic resection Proven slow transit constipation Proven upper GI dysmotility
Proven psychiatric disorder
Inconsistent evidence for combined
defaecation disorder
Rectal suspension High grade intussusception
(Oxford grade III-V)
Solitary rectal ulcer syndrome
(SRUS)Rectocoele
None established
Rectal excision Minimum of 3 ODS symptoms;
Functioning rectocoele
High grade intussusception
(Oxford grade III-V)
None established
Rectovaginal
reinforcement
Functioning and significantly-
sized rectocoele
None established None established
SNS Chronic constipation None established None established
ODS, obstructed defaecation symptoms.
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Table 6 (a-e) Graded practice recommendations
Evidence level Grade Median score Decision
(a)
Colonic resection
Patient selection
1. Given uncertainty of outcome and potential for harm, colectomy
should only be offered to patients when all other relevant
treatments have failed
IV C 9 Appropriate
2. Given concerns regarding outcome, the following represent
absolute or relative contra-indications to colectomy
a Concomitant upper GI symptoms (relative) V N 6 Uncertain
b Proven upper GI dysmotility (absolute) IV C 8 Uncertain
c Unproven generalised delay in colon transit (absolute) IV C 8 Appropriate
d Concomitant defecation disorder (relative) IV D 6 Uncertain
e Significant symptoms of abdominal pain and bloating, including diag-
nosis of IBS (relative)
IV D 6 Uncertain
f Faecal incontinence and/or functionally impaired anal sphincter V N 9 Appropriate
3. As a consequence of the above, colectomy should not be
considered without precision phenotyping (clinical and radio-
physiological)
IV C 9 Appropriate
4. Given concerns regarding outcome, magnitude and irreversibility
of colectomy, patients with concomitant defecation disorder
should have this treated first including surgery for structural
causes where relevant
IV D 8 Appropriate
5. All patients considered for colectomy should have specialist
multidisciplinary discussion
V N 9 Appropriate
6. Formal psychological evaluation should be undertaken in all
patients considered for colectomy for constipation
V N 7 Appropriate
7. In view of need for specialist investigations and review, patients
should only undergo colectomy for constipation in centres with
access to appropriate specialist services
V N 9 Appropriate
Procedural considerations
1. Colectomy and ileorectal anastomosis (CIRA) should be
considered the default option considering weight of evidence
compared to other procedures
IV C 8 Appropriate
2. There are insufficient data to conclude that the following provide
certain benefit in terms of clinical outcome in comparison to CIRA
• Subtotal or segmental resection IV C 8 Appropriate
• Subtypes of subtotal resection (caecorectal vs ileosigmoid) IV D 7 Appropriate
• Variations in anastomotic configuration (iso- or anti-peristaltic) IV D 7 Appropriate
• Laparoscopic vs open approach IV D 5 Uncertain
• Tailoring of segmental resections using specialist regional tran-
sit measurements
IV D 6 Uncertain
3. Laparoscopic surgery should be considered in suitable patients
because of:
• Modest reductions in length of stay IV D 8 Appropriate
• Cosmesis and other generally-perceived benefits e.g. reduced
incisional hernia
V N 8 Appropriate
• Possible reduction in long-term small bowel obstruction and
re-operation rates
IV D 8 Appropriate
Patient counselling
1. Approximately 85% patients report some benefit at follow up
greater than 1 year after colectomy
IV C 8 Appropriate
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Table 6 (Continued).
Evidence level Grade Median score Decision
2. Total perioperative complication rates vary greatly but may occur
in approximately 20–30% of colectomy patients regardless of
procedure choice, and include serious life-threatening
complications such as anastomotic leak (5% risk) and mortality
(0.4%)
IV C 8 Appropriate
3. Rates of post-operative ileus or early post-operative adhesional
small bowel obstruction vary greatly but occur in about 5–15% of
patients and about one-third of these patients require re-operation
regardless of procedure choice
IV C 8 Appropriate
4. Long-term adverse events characterized by recurrent episodes of
small bowel obstruction occur in about 10–20% of patients and
may result in a significant burden of re-hospitalization and
frequent recourse to surgery
IV C 8 Appropriate
5. Negative long term functional outcomes persist in a proportion of
patients: diarrhoea and incontinence in about 5–15% of patients;
abdominal pain in 30–50% of patients; recurrent constipation in
10–30% of patients and bloating in 10–40%
IV C 8 Appropriate
6. As a result of immediate and long-term complications,
approximately 5% patients will have a permanent ileostomy
IV C 6 Uncertain
(b)
Rectal suspension procedures
Patient selection
1. Rectal suspension procedures should be considered only for
patients failing appropriate non-surgical treatments
IV D 9 Appropriate
2. Rectal suspension procedures should be considered for patients
with the following anatomical abnormalities in conjunction with
symptoms suggestive of rectal evacuation disorder
• High grade intussusception (recto-anal e.g. Oxford grade: 3–5) IV C 8 Appropriate
• SRUS with associated intussusception IV C 8 Appropriate
3. Diagnosis of anatomical abnormalities should be conducted to a
standard where agreement exists that observed findings can be
deemed pathological based on appropriate normative data (derived
within the department or derived elsewhere but using identical
methodology e.g. for proctographic imaging)
V N 8 Appropriate
4. Given concerns regarding outcome, the following should be
regarded as relative contraindications to rectal suspension
procedures
• Significant psychiatric disorders V N 7 Appropriate
• Significant chronic pain syndromes including IBS V N 8 Appropriate
• Morbid obesity V N 8 Appropriate
• Known hostile abdomen/pelvis V N 8 Appropriate
• Joint hypermobility syndrome (EDS3)/connective tissue disor-
ders
V N 5 Uncertain
5. Patients considered for rectal suspension procedures should have
specialist multidisciplinary discussion
V N 8 Appropriate
6. In view of need for specialist investigations and review, patients
should only undergo rectal suspension procedures for constipation
in centres with access to appropriate specialist services
V N 8 Appropriate
7. Rectal suspension procedures (especially those employing mesh)
require special consideration in women who plan to become
pregnant
V N 8 Appropriate
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Table 6 (Continued).
Evidence level Grade Median score Decision
Procedural considerations
1. There is insufficient current evidence to conclude that any one
rectal suspension procedure is clearly superior to another
IV C 7 Appropriate
2. Laparoscopic surgery should be considered in suitable patients
because of:
• Cosmesis and other generally perceived benefits such as
reduced incisional hernia
V N 8 Appropriate
• Possible reduction in adhesion formation V N 8 Appropriate
• Superior access to the deep pelvis V N 7 Appropriate
3. There is no current evidence to suggest superiority of robotic
surgery over a standard laparoscopic approach
IV D 8 Appropriate
4. Careful consideration should be given to the type of mesh and
fixation
V N 8 Appropriate
Patient counselling
1. Approximately 83% (73–91%) patients report some benefit at
follow up greater than 1 year after rectal suspension procedures
IV C 8 Appropriate
2. Total perioperative complication rates vary greatly but may occur
in approximately 5–15% of patients regardless of procedure choice
IV C 8 Appropriate
3. Serious complications such as mesh erosion occur in 0–4% of
patients however no mortality has not been reported
IV C 8 Appropriate
4. The effect on constipation symptoms is highly variable and data
are only available for lap VMR after which most patients (86%)
report an improvement in constipation symptoms
IV C 7 Appropriate
5. In patients with SRUS, ulcer healing is observed in 78% of
patients
IV C 8 Appropriate
(c)
Rectal excisional procedures
Patient selection
1. Rectal excisional procedures should be considered only for
patients failing appropriate non-surgical treatments
II B 9 Appropriate
2. Rectal excisional procedures should be considered for patients
with the following anatomical abnormalities in conjunction with
symptoms suggestive of rectal evacuation disorder
• Minimum of 3 ODS symptoms II B 7 Appropriate
• Rectorectal or rectoanal intussusception only IV D 5 Uncertain
• Rectocele only II B 5 Uncertain
• Rectocele and intussusception II B 7 Appropriate
3. Diagnosis of anatomical abnormalities should be conducted to a
standard where agreement exists that observed findings can be
deemed pathological based on appropriate normative data (derived
within the department or derived elsewhere but using identical
methodology e.g. for proctographic imaging for grade of
intussusception and size/functionality of rectocele)
V N 8 Appropriate
4. Given concerns regarding outcome, the following should be
regarded as relative contraindications to rectal excisional
procedures although none were supported by evidence in the
systematic review
• Significant psychiatric disorders V N 8 Appropriate
• Significant chronic pain syndromes (including IBS) or perceived
susceptibility to chronic post-surgical pain
V N 8 Appropriate
• Concomitant enterocele (because of perceived risk of bowel
injury
V N 9 Appropriate
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Table 6 (Continued).
Evidence level Grade Median score Decision
• Reduced anal sphincter function (because of risk of urgency and
incontinence)
V N 7 Appropriate
• Solitary rectal ulcer syndrome V N 7 Appropriate
• Clear evidence of anal sphincter dyssynergia V N 7 Appropriate
• External rectal prolapse or other significant pelvic organ prolapse
syndrome
V N 9 Appropriate
5. Patients considered for rectal excisional procedures should have
specialist multidisciplinary discussion
V N 9 Appropriate
6. In view of need for specialist investigations and review, patients
should only undergo rectal excisional procedures for constipation
in centres with access to appropriate specialist services
V N 8 Appropriate
Procedural consideration
1. The evidence base of procedural choice is dominated by studies of
STARR procedures and all higher quality studies report STARR
outcomes; on this basis, it is reasonable to recommend STARR as
the default excisional procedure
II B 8 Appropriate
2. There is insufficient current evidence to conclude that any one
rectal excisional procedure is clearly superior to another in terms
of efficacy or complications
IV D 7 Appropriate
Patient counselling
1. Approximately 76% (73–80%) patients report some benefit at
follow up greater than 1 year after rectal excisional procedures
II B 7 Appropriate
2. Total perioperative complication rates vary greatly but may occur
in approximately 13–22% of patients regardless of procedure
choice
II B 7 Appropriate
3. Significant complications such as sepsis, anastomotic dehiscence
and bleeding occur in in approximately 2% (1–4%) of patients
II B 6 Uncertain
4. Life-threatening complications occur in in approximately 1: 1000
patients however no mortality was reported in recent review of
almost 6000 patients
II B 8 Appropriate
5. The effect on constipation symptoms is highly variable although
approximately 70% patients will obtain a significant reduction in
burden of obstructed defaecation symptoms
II B 7 Appropriate
6. Patients should be warned of long-term adverse functional
outcomes; rates of urgency (10%) and of chronic pain (2%) should
be cited
II B 8 Appropriate
7. Other long-term complications e.g. stenosis (< 1%)and fistula (1
in 1600) are rare
II B 7 Appropriate
(d)
Rectovaginal reinforcement
Patient selection
1. Rectovaginal reinforcement procedures should be considered for
patients with the following anatomical abnormalities in
conjunction with typical symptoms (vaginal bulging or prolapse
and problematic rectal evacuation)
• Significant dimensions (depth) based on clinical  imaging
assessment
IV C 7 Appropriate
• Evidence of functionality (trapping) on dynamic assessment IV C 8 Appropriate
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Table 6 (Continued).
Evidence level Grade Median score Decision
2. Diagnosis of the above should be conducted to a standard where
agreement exists that observed findings can be deemed
pathological based on appropriate normative data (derived within
the department or derived elsewhere but using identical
methodology e.g. for imaging)
V N 8 Appropriate
3. Given concerns regarding outcome the following should be
regarded as relative contraindications to all forms of rectovaginal
reinforcement procedures
• Diagnosis of major psychiatric disorders V N 7 Appropriate
• Significant chronic pain syndromes including IBS V N 7 Appropriate
• Morbid obesity V N 7 Appropriate
• High grade recto-anal intussusception V N 8 Uncertain
4. Procedure-specific relative contraindications should include:
• Vaginal repairs: smoking V N 5 Uncertain
• Transanal repairs: sphincter incompetence, rectal inflammation
or anorectal stenosis
V N 8 Appropriate
5. Patients considered for rectovaginal reinforcement procedures
should have specialist multidisciplinary discussion
V N 9 Appropriate
6. In view of need for specialist investigations and review, patients
should only undergo rectovaginal reinforcement procedures for
constipation in centres with access to appropriate specialist services
V N 8 Appropriate
7. Rectovaginal reinforcement procedures require special
consideration in women who plan to become pregnant
V N 8 Appropriate
Procedural considerations
1. There is insufficient evidence to conclude that any one
rectovaginal reinforcement procedure is clearly superior to another
for the treatment of constipation
IV C 8 Appropriate
2. Evidence derived from other indications for rectovaginal
reinforcement procedures e.g. pelvic organ prolapse syndromes
suggests superiority of vaginal repair (although this has not been
demonstrated in the treatment of constipation)
V N 5 Uncertain
3. Limited evidence suggests that a site specific vaginal repair may
lead to a higher recurrence rate than other surgical approaches
IV C 5 Uncertain
4. There is no evidence that the use of mesh reinforcement in vaginal
or perineal surgery leads to net benefit
IV C 7 Appropriate
Patient counselling
1. Approximately 73% (67–78%) patients report some benefit at
follow up after 1 year after rectovaginal reinforcement procedures
IV C 7 Appropriate
2. Total perioperative complication rates vary greatly but may occur
in approximately 7–17% of patients regardless of procedural choice
IV C 8 Appropriate
3. Serious complications such as rectovaginal fistula occur rarely (< 1
in 1000 patients); mortality has been reported in 1 in 1600
patients
IV C 8 Appropriate
4. While dyspareunia may occur with any of the surgical procedures,
the particular risks of a vaginal approach should be discussed with
the patient
IV D 9 Appropriate
5. Evidence derived from other indications for rectovaginal
reinforcement procedures e.g. pelvic organ prolapse syndromes
suggests an increased risk of dyspareunia with a vaginal repair in
conjunction with levatorplasty
V N 7 Appropriate
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type of approach and surgical instruments (flippantly
whether the surgeon prefers basic surgical instruments,
laparoscopy or staplers). With respect to complications,
limited reporting prevented much discussion beyond
the importance of counselling patients about established
complications (covered in GPRs). However, it is tempt-
ing to speculate that future stratification might provide
the opportunity to select patients for one or other pro-
cedure e.g. avoiding patients with certain prior pheno-
typic features or modifying risk. An example would be
chronic pain development, where perhaps STARR
should be relatively contra-indicated in patients with
preceding evidence of pain syndromes (e.g. migraine,
fibromyalgia or chronic back pain) or modified using
one of a number of available agents to prevent sensitiza-
tion during surgery e.g. pre-operative gabapentin or
intra-operative ketamine [5]. At the very least the data
provide the opportunity to appraise patients with the
options and their complication profiles where more than
one surgical option exists.
Another difficulty with interpretation was that inclu-
sion (in the review) necessarily reflected the availability
of studies, in turn reflecting the tendency to publish
studies of new techniques rather than well-established
ones. Higher quality data were available for rectal exci-
sional procedures due to several prospective cohort
studies and small RCTs of the STARR procedure (and
variations). It is well acknowledged that this body of
data, including over 8000 patients, reflects a period of
intense popularity for this procedure (nearly all pub-
lished in the decade 2004–14) with (interestingly) no
included papers arising from the final 18 months of the
review period. The large numbers are also known to
reflect industry investment in several data registries, two
of which included over 2000 patients. Anecdotal evi-
dence and expert opinion from international meetings is
that the popularity for this procedure has waned (even
in Italy – the origin of the procedure and its main pro-
ponents). Such a peak and decline in popularity was not
present for other procedures that were more evenly
spread across the review period.
Graded practice recommendations
The clinical guidelines group developed a total of 100
‘prototype’ graded practice recommendations by taking
forward summary evidence statements from the five
reviews and combining these with expert opinion and a
small number of RCTs (SNS only) published after the
extraction data (22/02/2016). These statements cov-
ered patient selection, procedural considerations and
patient counselling. The limitations in review evidence
meant that only 59/100 prototype GPRs were directly
derived from summary evidence (level II-IV; grades B-
D) with the remainder, 41/100 derived by expert opin-
ion only (level V; grade N). Of the 100 total, 85 were
deemed ‘appropriate’ based on the independent scoring
of 18 European experts and the remaining 15 were all
Table 6 (Continued).
Evidence level Grade Median score Decision
(e)
Sacral nerve stimulation
Patient selection
1. Recent trial data (from 2 independent RCTs) suggest no overall
benefit of SNS for chronic constipation regardless of type of
constipation; on this basis, the procedure cannot be recommended
for this indication
II B 7 Appropriate
Procedural considerations
1. Not applicable (follow manufacturer’s instructions and specific
training)
NA NA NA NA
Patient counselling
1. Patients should be counselled that the evidence base does not
support the use of SNS for chronic constipation
II B 9 Appropriate
2. If performed, patients should be warned of:
• Highly variable rates of device removal for adverse effects or
lack of efficacy
IV D 8 Appropriate
• Very high rates of reprogramming IV D 8 Appropriate
• Low eventual success rates II B 9 Appropriate
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deemed uncertain, i.e. none was considered inappropri-
ate by the panel. This is a high level of consensus for a
single round of questioning and suggests that there is
reasonable European agreement as to selection of
patients for each class of procedure, which procedure to
perform and how to counsel the patient (often related
to outlining potential harms). However, this does not
signify unequivocal evidence of value for these recom-
mendations and they do not represent minimum stan-
dards, but can act as a basis for further research and
guideline development.
The 15 ‘uncertain’ GPRs were spread across proce-
dures with most in colectomy (n = 7) and least for
rectal suspension (1) and SNS (0). The majority con-
cerned patient selection (n = 8). Interestingly, only 5/
15 (33.3%) related to prototype GPRs based only on
expert opinion (level V, grade N). The remaining 10
included five where uncertainty by consensus accurately
reflected uncertainty by grade (D) (33.3%), three with
grade C summary evidence from the systematic reviews
(20.0%) and two with grade B evidence (13.3%).
There was thus no strong suggestion that grade
weighed panelist opinion. The two grade B statements
deemed uncertain both concerned rectal excision: first
that ‘rectocoele only’ was an indication in terms of
benefiting the patient; and secondly that significant
complications such as sepsis, anastomotic dehiscence
and bleeding can occur post-procedure in approxi-
mately 2% (1–4%) of patients. The panelist consensus
on these two GPRs is surprising since both would
seem to reflect widespread practice and knowledge,
respectively. Overall, while it would be possible to
have further rounds of consensus building among the
European panel, the GPRs as stands are a good start
to develop future clinical guidelines.
Future research recommendations
With the exception of rectal excision, there are clear
deficiencies in the current evidence base for all surgical
procedures directed at the management of chronic con-
stipation in adults. This was particularly true in terms of
availability of randomized controlled trials, where only
four reviewed studies met criteria for level I evidence.
The difficulties in conducting randomized trials for
complex interventions such as surgery are well rehearsed
[6], but their importance is exemplified by recent SNS
RCTs [3,4] that directly contradict observational data.
While it can be argued that sham surgery would be dif-
ficult to justify for patients with a chronic debilitating
condition, it is disappointing that no level I evidence
has been produced to compare classes of procedure
where more than one is appropriate. Such comparison
trials of different techniques may face problems of equi-
poise and interventional fidelity, and might need to
overcome a speciality divide e.g. posterior repair vs
transanal repair of rectocoele (the former performed lar-
gely by gynaecologists or urologists specializing in
female patients and the latter by colorectal surgeons).
An alternative is waiting-list designs where the wait time
for surgery can be randomized and analysis-based on
longitudinal outcomes before and after intervention [7].
An example of such a study is the CapaCiTY03
stepped-wedge randomised controlled study of laparo-
scopic ventral mesh rectopexy in adults with chronic
constipation [8].
Accepting the difficulty in performing RCTs, there is
still much opportunity to improve the evidence base by
encouraging high quality observational studies. Prospec-
tive cohort studies could benefit from incorporating
some of the scientific rigor of RCTs to limit obvious
sources of bias e.g. by multicentre recruitment and use
of blinded observers to collect outcomes. Awareness of
reporting standards by authors and journals may in turn
feed better protocol-driven research [9]. They should
incorporate the few validated patient-reported outcome
measures (PROMS) that are available e.g. PAC-QoL
and PAC-SYM, internationally-accepted HR-QoL mea-
sures e.g. EQ-5D-5L and monitor harms in a systematic
manner using established systems e.g. Clavien-Dindo
[6]. They should also consider collecting health utiliza-
tion data from patient information systems, the impor-
tance of which is illustrated by the Dudekula study [1]
of colectomy.
The CCG make the following recommendations as
research priorities:
1 Colonic resection: there is a need to determine
prospectively and robustly the risks and benefits of
this procedure. Considering its low incidence, a
prospective cohort study across Europe (or interna-
tionally) is recommended. Observer-blinded out-
comes (above) should be systematically recorded at
regular intervals to 5 years. Standardised baseline
phenotyping may permit determination of outcome
predictors if numbers are large enough. Considera-
tion could be given to a control group not undergo-
ing surgery (although selection bias is
acknowledged). All procedural variations could be
evaluated although the main comparison of interest
is now considered to be between more (total colec-
tomy) and less radical (subtotal) laparoscopic resec-
tions. A double-blind RCT of this latter comparison
might also be possible with international effort.
2 Rectal procedures for dynamic structural abnormali-
ties of the pelvic floor. A UK RCT is underway to
evaluate laparoscopic ventral mesh rectopexy [8]. A
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further RCT is however recommended to determine
outcomes of repair of large rectocoele (in isolation),
comparing posterior repair of the vagina vs transanal
repair. It is acknowledged that this might require an
expertise-based design [6,10] but it is an unanswered
question for the indication of chronic constipation or
obstructed defaecation. Systematic review data would
also support a randomized comparison of STARR
with rectopexy for patients with high-grade intussus-
ception and rectocoele. However, expert opinion sug-
gests that STARR is no longer popular. An alternative
would be to perform a prospective cohort study (akin
to colectomy) capturing all current practice. This
could be performed internationally but might also be
possible in a single country where all three main
classes of procedure are still commonly utilized.
Conclusions
This manuscript concludes the series of seven, systemat-
ically detailing the outcomes of the main surgical proce-
dures directed toward patients with chronic
constipation. The current evidence base is poor and
heavily reliant on low-quality observational data. On
this basis, all procedures reviewed had generally positive
(supportive) data. Several authors expressed concern
that such data might not reflect the reality of clinical
practice. While bias in such observational study designs
is well recognized, it is possible that in surgical studies
(usually performed by the proponents of the surgery)
bias is both unidirectional (favouring the intervention)
and powerful. Not only should this lead to a greater
willingness to design and deliver high quality controlled
trials, but also to an essential understanding that retro-
spective observational studies should be interpreted with
caution. However the finding of widespread consensus
for graded practice recommendations is encouraging.
The stage is now set for recognised professional bodies
worldwide e.g. Societies of Coloproctology/Colorectal
surgery to build on this work by supporting the efforts
of their membership to address future research recom-
mendations and/or to help convert the recommenda-
tions documented in this series of papers into their
clinical guidelines.
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